- Home
- RVYL vs CLDI Comparison
RVYL vs CLDI Comparison
Compare RVYL & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVYL
- CLDI
- Stock Information
- Founded
- RVYL 2007
- CLDI 2014
- Country
- RVYL United States
- CLDI United States
- Employees
- RVYL N/A
- CLDI N/A
- Industry
- RVYL Professional Services
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RVYL Consumer Discretionary
- CLDI Health Care
- Exchange
- RVYL Nasdaq
- CLDI Nasdaq
- Market Cap
- RVYL 7.3M
- CLDI 8.7M
- IPO Year
- RVYL N/A
- CLDI N/A
- Fundamental
- Price
- RVYL $0.31
- CLDI $1.49
- Analyst Decision
- RVYL Hold
- CLDI
- Analyst Count
- RVYL 1
- CLDI 0
- Target Price
- RVYL N/A
- CLDI N/A
- AVG Volume (30 Days)
- RVYL 9.6M
- CLDI 231.9K
- Earning Date
- RVYL 11-13-2025
- CLDI 11-07-2025
- Dividend Yield
- RVYL N/A
- CLDI N/A
- EPS Growth
- RVYL N/A
- CLDI N/A
- EPS
- RVYL N/A
- CLDI N/A
- Revenue
- RVYL $48,904,000.00
- CLDI N/A
- Revenue This Year
- RVYL N/A
- CLDI N/A
- Revenue Next Year
- RVYL $297.49
- CLDI N/A
- P/E Ratio
- RVYL N/A
- CLDI N/A
- Revenue Growth
- RVYL N/A
- CLDI N/A
- 52 Week Low
- RVYL $0.25
- CLDI $1.10
- 52 Week High
- RVYL $2.33
- CLDI $46.68
- Technical
- Relative Strength Index (RSI)
- RVYL 50.97
- CLDI 47.51
- Support Level
- RVYL $0.28
- CLDI $1.10
- Resistance Level
- RVYL $0.30
- CLDI $1.56
- Average True Range (ATR)
- RVYL 0.06
- CLDI 0.14
- MACD
- RVYL -0.00
- CLDI 0.01
- Stochastic Oscillator
- RVYL 21.29
- CLDI 69.49
About RVYL Ryvyl Inc.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.